Superior protection conferred by inactivated whole virus vaccine over subunit and DNA vaccines against salmonid alphavirus infection in Atlantic salmon (Salmo salar L.)

Vaccine

Volumn 30, Issue 26, 2012, Pages 3918-3928

  Xu, Cheng ^a   Mutoloki, Stephen ^a   Evensen, Øystein ^a  

^a NORWEGIAN UNIVERSITY OF LIFE SCIENCES   (Norway)

Author keywords

Protection; Recombinant vaccines; Salmonid alphavirus; Vaccination; Whole virus vaccines

Indexed keywords

DNA VACCINE; GAMMA INTERFERON; GLYCOPROTEIN E1; GLYCOPROTEIN E2; INACTIVATED VIRUS VACCINE; INTERLEUKIN 2; MESSENGER RNA; NEUTRALIZING ANTIBODY; SALMONID ALPHAVIRUS 3 VACCINE; SUBUNIT VACCINE; UNCLASSIFIED DRUG; WATER OIL CREAM;

ALPHAVIRUS INFECTION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIBODY BLOOD LEVEL; ANTIBODY RESPONSE; ANTIBODY TITER; ARTICLE; ATLANTIC SALMON; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; EPICARDIUM; FISH DISEASE; GENE EXPRESSION; HEART ATRIUM; HEART VENTRICLE; HISTOPATHOLOGY; IMMUNIZATION; IMMUNOGENICITY; IMMUNOHISTOCHEMISTRY; MORTALITY; NONHUMAN; NUCLEOTIDE SEQUENCE; PANCREAS; PRIORITY JOURNAL; PROTEIN EXPRESSION; SKELETAL MUSCLE; SURVIVAL; UPREGULATION; VIRUS NEUTRALIZATION; VIRUS REPLICATION;

ADJUVANTS, IMMUNOLOGIC; ALPHAVIRUS; ALPHAVIRUS INFECTIONS; ANIMALS; ANTIBODIES, NEUTRALIZING; ANTIBODIES, VIRAL; FISH DISEASES; OILS; SALMO SALAR; SURVIVAL ANALYSIS; VACCINES, DNA; VACCINES, INACTIVATED; VACCINES, SUBUNIT; VIRAL ENVELOPE PROTEINS; VIRAL VACCINES;

EID: 84861190935     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2012.03.081     Document Type: Article

References (34)

1. Munro A.L.S., Ellis A.E., Mcvicar A.H., Mclay H.A., Needham E.A. An exocrine pancreas disease of farmed Atlantic salmon in Scotland. Helgolander Meeresuntersuchungen 1984, 37(1-4):571-586.
2. Mcvicar A.H. Pancreas disease of farmed Atlantic salmon, Salmo-salar, in Scotland - epidemiology and early pathology. Aquaculture 1987, 67(December (1-2)):71-78.
3. Murphy T.M., Rodger H.D., Drinan E.M., Gannon F., Kruse P., Korting W. The sequential pathology of pancreas disease in Atlantic salmon farms in Ireland. Journal of Fish Diseases 1992, 15(September (5)):401-408.
4. Rodger H.D., Turnbull T., Richards R.H. Myopathy and pancreas disease in salmon - a retrospective study in Scotland. Veterinary Record 1994, 135(September (10)):234-235.
5. Nelson R.T., McLoughlin M.F., Rowley H.M., Platten M.A., McCormick J.I. Isolation of a toga-like virus from farmed Atlantic salmon Salmo-salar with pancreas disease. Diseases of Aquatic Organisms 1995, 22(May (1)):25-32.
6. Weston J.H., Welsh M.D., McLoughlin M.F., Todd D. Salmon pancreas disease virus, an alphavirus infecting farmed Atlantic salmon, Salmo salar L. Virology 1999, 256(April (2)):188-195.
7. Hodneland K., Bratland A., Christie K.E., Endresen C., Nylund A. New subtype of salmonid alphavirus (SAV), Togaviridae, from Atlantic salmon Salmo salar and rainbow trout Oncorhynchus mykiss in Norway. Diseases of Aquatic Organisms 2005, 66(September (2)):113-120.
8. Gahlawat S.K., Ellis A.E., Collet B. Expression of interferon and interferon - induced genes in Atlantic salmon Salmo salar cell lines SHK-1 and TO following infection with Salmon AlphaVirus SAV. Fish & Shellfish Immunology 2009, 26(April (4)):672-675.
9. Xu C., Guo T.C., Mutoloki S., Haugland O., Marjara I.S., Evensen O., et al. Alpha interferon and not gamma interferon inhibits salmonid alphavirus subtype 3 replication in vitro. Journal of Virology 2010, 84(September (17)):8903-8912.
10. McLoughlin M.F., Nelson R.T., Rowley H.M., Cox D.I., Grant A.N. Experimental pancreas disease in Atlantic salmon Salmo salar post-smolts induced by salmon pancreas disease virus (SPDV). Diseases of Aquatic Organisms 1996, 26(August (2)):117-124.
11. Houghton G., Ellis A.E. Pancreas disease in Atlantic salmon: serum neutralisation and passive immunisation. Fish & Shellfish Immunology 1996, 6(August (6)):465-472.
12. Ryman K.D., Klimstra W.B., Nguyen K.B., Biron C.A., Johnston R.E. Alpha/beta interferon protects adult mice from fatal Sindbis virus infection and is an important determinant of cell and tissue tropism. Journal of Virology 2000, 74(April (7)):3366-3378.
13. Griffin D.E. Roles and reactivities of antibodies to alphaviruses. Seminars in Virology 1995, 6(August (4)):249-255.
14. Strauss J.H., Strauss E.G. The alphaviruses - gene-expression, replication, and evolution (Vol 58, Pg 496, 1994). Microbiological Reviews 1994, 58(December (4)):806.
15. Paredes A.M., Heidner H., Thuman-Commike P., Prasad B.V.V., Johnston R.E., Chiu W. Structural localization of the E3 glycoprotein in attenuated Sindbis virus mutants. Journal of Virology 1998, 72(February (2)):1534-1541.
16. Roehrig J.T., Hunt A.R., Kinney R.M., Mathews J.H. Invitro mechanisms of monoclonal-antibody neutralization of alphaviruses. Virology 1988, 165(July (1)):66-73.
17. Strauss E.G., Stec D.S., Schmaljohn A.L., Strauss J.H. Identification of antigenically important domains in the glycoproteins of Sindbis virus by analysis of antibody escape variants. Journal of Virology 1991, 65(September (9)):4654-4664.
18. Schmaljohn A.L., Johnson E.D., Dalrymple J.M., Cole G.A. Non-neutralizing monoclonal-antibodies can prevent lethal alphavirus encephalitis. Nature 1982, 297(5861):70-72.
19. Mendoza Q.P., Stanley J., Griffin D.E. Monoclonal-antibodies to the E1-glycoproteins and E2-glycoproteins of Sindbis virus - definition of epitopes and efficiency of protection from fatal encephalitis. Journal of General Virology 1988, 69(December):3015-3022.
20. Ubol S., Levine B., Lee S.H., Greenspan N.S., Griffin D.E. Roles of immunoglobulin valency and the heavy-chain constant domain in antibody-mediated downregulation of Sindbis virus replication in persistently infected neurons. Journal of Virology 1995, 69(March (3)):1990-1993.
21. Mathews J.H., Roehrig J.T., Trent D.W. Role of complement and the Fc portion of immunoglobulin G in immunity to Venezuelan equine encephalomyelitis virus infection with glycoprotein-specific monoclonal antibodies. Journal of Virology 1985, 55(September (3)):594-600.
22. Hirsch R.L., Griffin D.E., Johnson R.T. Interactions between immune cells and antibody in protection from fatal Sindbis virus encephalitis. Infection and Immunity 1979, 23(February (2)):320-324.
23. Das D., Gares S.L., Nagata L.P., Suresh M.R. Evaluation of a Western Equine Encephalitis recombinant E1 protein for protective immunity and diagnostics. Antiviral Research 2004, 64(November (2)):85-92.
24. Das D., Nagata L.P., Suresh M.R. Immunological evaluation of Escherichia coli expressed E2 protein of Western equine encephalitis virus. Virus Research 2007, 128(September (1-2)):26-33.
25. Wang K.S., Strauss J.H. Use of a lambda-Gt11 expression library to localize a neutralizing antibody-binding site in glycoprotein-E2 of Sindbis virus. Journal of Virology 1991, 65(December (12)):7037-7040.
26. Beyer W.E.P., Palache A.M., Osterhaus A.D.M.E. Comparison of serology and reactogenicity between influenza subunit vaccines and whole virus or split vaccines - a review and meta-analysis of the literature. Clinical Drug Investigation 1998, 15(January (1)):1-12.
27. Stephenson I., Nicholson K.G., Glück R., Mischler R., Newman R.W., Palache A.M., et al. Safety and antigenicity of whole virus and subunit influenza A/Hong Kong/1073/99 (H9N2) vaccine in healthy adults: phase I randomised trial. Lancet 2003, 362(December (9400)):1959-1966.
28. Geeraedts F., Goutagny N., Hornung V., Severa M., de Haan A., Pool J., et al. Superior immunogenicity of inactivated whole virus H5N1 influenza vaccine is primarily controlled by Toll-like receptor signalling. Plos Pathogens 2008, 4(August (8)):e1000138.
29. Ahsan F.L., Rivas I.P., Khan M.A., Suarez A.I.T. Targeting to macrophages: role of physicochemical properties of particulate carriers - liposomes and microspheres - on the phagocytosis by macrophages. Journal of Controlled Release 2002, 79(February (1-3)):29-40.
30. Restifo N.P., Ying H., Hwang L., Leitner W.W. The promise of nucleic acid vaccines. Gene Therapy 2000, 7(January (2)):89-92.
31. Whitton J.L., Rodriguez F., Zhang J., Hassett D.E. DNA immunization: mechanistic studies. Vaccine 1999, 17(March (13-14)):1612-1619.
32. La Linn M., Mateo L., Gardner J., Suhrbier A. Alphavirus-specific cytotoxic T lymphocytes recognize a cross-reactive epitope from the capsid protein and can eliminate virus from persistently infected macrophages. Journal of Virology 1998, 72(June (6)):5146-5153.
33. Dupuy L.C., Richards M.J., Reed D.S., Schmaljohn C.S. Immunogenicity and protective efficacy of a DNA vaccine against Venezuelan equine encephalitis virus aerosol challenge in nonhuman primates. Vaccine 2010, 28(October (46)):7345-7350.
34. Nagata L.P., Hu W.G., Masri S.A., Rayner G.A., Schmaltz F.L., Das D., et al. Efficacy of DNA vaccination against western equine encephalitis virus infection. Vaccine 2005, 23(March (17-18)):2280-2283.